Doximity, Inc. $DOCS Shares Sold by Fielder Capital Group LLC

Fielder Capital Group LLC lessened its holdings in Doximity, Inc. (NASDAQ:DOCS) by 10.4% in the 2nd quarter, Holdings Channel.com reports. The firm owned 5,204 shares of the company’s stock after selling 602 shares during the quarter. Fielder Capital Group LLC’s holdings in Doximity were worth $319,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of DOCS. VSM Wealth Advisory LLC purchased a new stake in Doximity during the 1st quarter worth approximately $29,000. Allworth Financial LP grew its position in shares of Doximity by 104.0% in the first quarter. Allworth Financial LP now owns 563 shares of the company’s stock valued at $32,000 after purchasing an additional 287 shares in the last quarter. National Bank of Canada FI purchased a new stake in shares of Doximity in the first quarter valued at approximately $33,000. Spire Wealth Management grew its position in Doximity by 73.2% in the first quarter. Spire Wealth Management now owns 615 shares of the company’s stock worth $36,000 after acquiring an additional 260 shares during the period. Finally, Brooklyn Investment Group grew its position in Doximity by 70.7% in the first quarter. Brooklyn Investment Group now owns 746 shares of the company’s stock worth $43,000 after acquiring an additional 309 shares during the period. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Price Performance

Doximity stock opened at $66.93 on Friday. Doximity, Inc. has a 1-year low of $40.87 and a 1-year high of $85.21. The stock has a market cap of $12.54 billion, a PE ratio of 66.93, a P/E/G ratio of 4.10 and a beta of 1.38. The stock’s fifty day moving average is $69.60 and its two-hundred day moving average is $61.73.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period in the previous year, the firm earned $0.28 EPS. The business’s revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, research analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Insider Buying and Selling at Doximity

In other Doximity news, Director Regina M. Benjamin sold 5,000 shares of the firm’s stock in a transaction on Friday, October 10th. The stock was sold at an average price of $70.84, for a total value of $354,200.00. Following the sale, the director directly owned 19,839 shares in the company, valued at $1,405,394.76. This trade represents a 20.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction on Wednesday, September 24th. The shares were sold at an average price of $75.00, for a total value of $1,500,000.00. Following the completion of the sale, the director owned 3,221 shares in the company, valued at approximately $241,575. This represents a 86.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 37,000 shares of company stock worth $2,635,880 over the last ninety days. Corporate insiders own 31.30% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently issued reports on the company. Raymond James Financial set a $75.00 price objective on Doximity in a research note on Wednesday, September 10th. JPMorgan Chase & Co. reiterated an “underweight” rating and issued a $62.00 price objective on shares of Doximity in a research note on Friday, October 10th. Needham & Company LLC increased their price objective on Doximity from $67.00 to $75.00 and gave the company a “buy” rating in a research note on Friday, August 8th. The Goldman Sachs Group set a $64.00 price objective on Doximity and gave the company a “sell” rating in a research note on Wednesday, October 1st. Finally, KeyCorp increased their price objective on Doximity from $75.00 to $80.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, Doximity has an average rating of “Hold” and an average target price of $69.37.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.